In addition, HMMR-V3 splice variant, which lacks a microtubule-binding domain and is associated with poor survival in patients with MM, was expressed alone in 34% of the myeloid cells and in 11% of the PCs in patients with RRMM (Fig. 2B) [27]. Here, HMMR is linked to Miyoshi myopathy.